Trends in Breast Cancer Mortality Between 2001 and 2017: An Observational Study in Europe and the UK - European Medical Journal

Continue

Trends in Breast Cancer Mortality Between 2001 and 2017: An Observational Study in Europe and the UK

1 Mins
Oncology
EMJ Oncology 8.1 2020 Feature Image
Authors:
*Chinmay Jani,1,2 Ingrid Salciccioli,3 Richard Goodall,4 Justin D. Salciccioli,2,5 Dominic C. Marshall,6 Harpreet Singh,1,2 Joseph Shalhoub4,7

1. Department of Medicine, Mount Auburn Hospital/Beth Israel Lahey Health, Cambridge, Massachusetts, USA
2. Harvard Medical School, Boston, Massachusetts, USA
3. Harvard T.H. School of Public Health, Boston, Massachusetts, USA
4. Department of Surgery and Cancer, Imperial College London, UK
5. Division of Pulmonary and Critical Care, Brigham and Women’s Hospital, Boston, Massachusetts, USA
6. National Heart and Lung Institute, Imperial College London, London, UK
7. Imperial Vascular Unit, Imperial College Healthcare NHS Trust, London, UK
*Correspondence to [email protected]

Disclosure:

The authors have declared no conflicts of interest.

Citation:
EMJ Oncol. ;8[1]:45-46. Abstract Review No. AR2.
Keywords:
Breast cancer, Europe, trends, World Health Organization (WHO) Mortality Database.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

BACKGROUND

The global incidence of breast cancer was 1.96 million cases in 2017, making it the third highest incident cancer.1 In Europe, breast cancer is the second most common cancer, accounting for 11.6% of cancer cases in males and females.2 Mammography screening programmes reduce the rate of advanced breast cancer,3 with some estimating a mortality reduction of 26% in Europe.4 Male breast cancer is rare: the 1993 incidence in Europe was 1 in 100,000.5 In the USA, male breast cancer has been rising from 0.96 cases per 100,000 males in 1975 to 1.32 per 100,000 in 2017.6 Because of the availability of enhanced treatment options, as well as improved detection, breast cancer mortality is falling in most European countries.7,8 Here, the authors present trends in breast cancer mortality in both males and females across Europe.

MATERIALS AND METHODS

The World Health Organization (WHO) Mortality Database was utilised to extract breast cancer mortality data, based on the International Classification of Diseases 10th revision (ICD 10), from 2001 to 2017. Twenty-four member states of the European Union (EU) and the UK were selected as a defined group for analysis. Crude mortality rates were dichotomised by sex and reported by year. The age-standardised death rates (ASDR) per 100,000 population using the World Standard Population were computed. Breast cancer mortality trends were described using Joinpoint regression analysis. In brief, Joinpoint analysis assesses the overall trends in mortality, initially with no Joinpoints, and tests for significant changes in the model with the sequential addition of Joinpoints where there are significant changes in the slope of the line. As the data source was a publically available database with no patient identifiable information, institutional review board approval was not necessary for the study.

RESULTS

Of the 25 countries analysed, five countries had data until 2017, 12 until 2016, six until 2015, and one until 2014. It was observed that mortality in females was down-trending in all countries except Croatia, France, and Poland. Among all the nations studied, most recently (2016) Croatia had the highest ASDR (19.29/100,000), whereas the lowest mortality was in Spain (12.8/100,000) (Supplementary Figure 1). Estonia had the highest estimated annual percentage change (EAPC) in female breast mortality (-9.3%). Denmark had the highest change in ASDR (+28.0% in 2000 versus +16.7% in 2015). It was observed that breast cancer mortality in males decreased in 18 countries. Among all the nations studied, Bulgaria had the highest male breast cancer mortality (0.54/100,000) in the year 2015, whereas Denmark had the greatest EAPC (-27.5%) for the years 2012–2015.

CONCLUSION

Across the 17-year study period, a decrease in breast cancer mortality in females in the majority of the countries was observed. There was substantial variation between the European nations. Breast cancer mortality in males continues to increase in a number of European countries.

References
World Health Organization (WHO). Fact sheets. Geneva: World Health Organization. 2020. Available at: https://www.who.int/news-room/fact-sheets/detail/cancer. Last accessed: 3 May 2020. Bray F et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. Autier P et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ. 2010;341:c3620. Koczkodaj P et al. Breast cancer mortality trends in Europe among women in perimenopausal and postmenopausal age (45+). Arch Med Sci. 2020;16(1):146-56. Sasco AJ et al. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer. 1993;53:538-49. National Institute of Health (NIH). Surveillance, epidemiology, and end results program. SEER cancer statistics review (CSR). 2018. Available at: https://seer.cancer.gov/csr/1975_2014. Last accessed: 7 October 2020. Zielonke N et al. Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: a systematic review. Eur J Cancer. 2020;127:191-206. Amaro J et al. Patterns of breast cancer mortality trends in Europe. Breast. 2013;22(3):244-53.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.